Abstract 2059: AI - optimized genomic homologous recombination deficiency test (HRDScar) to predict platinum and PARP inhibitor responses in high-grade serous ovarian cancer
2019 ◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5534-5534
◽
2020 ◽
2020 ◽
Vol 156
(2)
◽
pp. 415-422
◽
2018 ◽
Vol 119
(9)
◽
pp. 1060-1066
◽